You will be shown a claim about public health, and the abstract of a biomedical research paper. Each sentence from the abstract will be on a separate line. Your task is to return a JSON object with two fields:

- "verdict": The fact-checking verdict. If the information in the abstract supports the claim, write "SUPPORT". If the abstract contradicts the claim, write "CONTRADICT". If the abstract does not provide enough information to arrive at a verdict, write "NEI" (for "not enough information").
- "evidence": An array of sentences providing evidence for the verdict. Please copy all relevant sentences verbatim from the abstract. If the verdict was "NEI", then return an empty array.

For instance, if the model were given the claim "wearing masks can prevent the spread of COVID", the output might be
{
  "verdict": "SUPPORT",
  "evidence": ["Our findings indicate that mass mask-wearing reduces the transmission rate for COVID-19."]
}

Claim: Vitamin C infusion can help improve the prognosis of patients with SARI.

Abstract:
BACKGROUND The coronavirus disease 2019 (COVID-19) pandemic has affected almost 2.5 million people worldwide with almost 170 000 deaths reported to date.
So far, there is scarce evidence for the current treatment options available for COVID-19.
Vitamin C has previously been used for treatment of severe sepsis and septic shock.
We reviewed the feasibility of using vitamin C in the setting of COVID-19 in a series of patients.
METHODS We sequentially identified a series of patients who were requiring at least 30% of FiO2 or more who received IV vitamin C as part of the COVID-19 treatment and analyzed their demographic and clinical characteristics.
We compared inflammatory markers pre and post treatment including D-dimer and ferritin.
RESULTS We identified a total of 17 patients who received IV vitamin C for COVID-19.
The inpatient mortality rate in this series was 12% with 17.6% rates of intubation and mechanical ventilation.
We noted a significant decrease in inflammatory markers, including ferritin and D-dimer, and a trend to decreasing FiO2 requirements, after vitamin C administration.
CONCLUSION The use of IV vitamin C in patients with moderate to severe COVID-19 disease may be feasible.
{"verdict": "NEI", "evidence": []}